Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-CD38 antibodies for treatment of acute lymphoblastic leukemia

Anti-CD38 antibodies for treatment of acute lymphoblastic leukemia

US Patent 10556961 · Granted Feb 11, 2020

Estimated economic value: $118,021,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-CD38 antibodies for treatment of acute myeloid leukemia2025
Anti-CD38 antibodies for treatment of light chain amyloidosis and other CD38-pos2024
Combination therapies with anti-CD38 antibodies2024
Anti-CD38 antibodies for treatment of acute lymphoblastic leukemia2023
Combination therapies with anti-CD38 antibodies2020
Anti-CD38 antibodies for treatment of acute myeloid leukemia2020
Anti-CD38 antibodies for treatment of light chain amyloidosis and other CD38-pos2020
Combination therapies for heme malignancies with anti-CD38 antibodies and surviv2020
Anti-CD38 antibodies for treatment of acute lymphoblastic leukemia2017
Combination therapies with anti-CD38 antibodies2017
Indolinone protein kinase inhibitors and cyclooxygenase inhibitors for use in co2008